Abiopharma

Director Kelly Paul Edward 🟢 acquired 828.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 ($3.4M) Transaction Date: Dec 12, 2025 | Filing ID: 121968

Director CASAMENTO CHARLES J 🟢 acquired 164.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 Transaction Date: Dec 12, 2025 | Filing ID: 121967

Grifols Sa (GIFLF) Files Form 6-K

CAN FITE BIO (CANF) Files Form 6-K

Can-Fite Provides Update on Clinical and Financial Status

Can-Fite Provides Update on Clinical and Financial Status

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Oncolytics Biotech Inc (ONCY) Files Form 6-K

Director Williams Gregg 🟢 acquired 1.7M shares of Vivani Medical, Inc. (VANI) at $1.26 ($2.0M) Transaction Date: Dec 15, 2025 | Filing ID: 001892

Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

Integer Holdings Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR

Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP

Director Titterton Lewis H jr 🟡 adjusted position in 0 shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $2.92 Transaction Date: Dec 15, 2025 | Filing ID: 027904

New Form 424B3 - Azitra, Inc. Filed: 2025-12-16 AccNo: 0001493152-25-027900 Size: 463 KB

GSK plc (GLAXF) Files Form 6-K